The Revogene® automates sample homogenization, sample dilution, cells lysis, DNA amplification and detection of the amplified PCR products. User intervention is only required for discharging the patient specimen into the Sample Buffer Tube (SBT), transferring the sample into the PIE, and loading/unloading the PIEs into the revogene carousel.
Each PIE is a completely integrated closed device in which a sample is dispensed and processed through different microfluidic chambers and channels which allow for the sample processing (i.e. homogenization, sample dilution, and cells lysis) and subsequent Real‐time PCR steps.
Revogene® C. difficile
The Revogene® C. difficile assay is a qualitative in vitro diagnostic test that utilizes automated sample processing and real‐time polymerase chain reaction (PCR) to detect the toxin B (tcdB) gene of toxigenic Clostridium difficile (C. difficile) in unformed (liquid or soft) stool specimens obtained from patients suspected of having C. difficile infection (CDI).
Revogene® GBS DS
The Revogene® GBS DS assay is a qualitative in vitro diagnostic test designed to detect Group B Streptococcus (GBS) DNA from vaginal/rectal swabs obtained from pregnant women. The assay utilizes automated sample processing and real-time polymerase chain reaction (PCR) to detect a cfb gene sequence specific to the Streptococcus agalactiae genome.
Revogene® Carba C
The Revogene® Carba C assay provides healthcare systems with a diagnostic solution to enable early detection and management of Carbapenem-Resistant Enterobacteriaceae (CRE) from isolated colonies of Enterobacteriaceae, Acinetobacter baumannii, or Pseudomonas aeruginosa.